Merck

On target clinical trial success bullseye score
Pharma

Keytruda, Padcev cut risk of death by 50% in MIBC patient subset

The perioperative PD-1/ADC combo also significantly improved event-free survival by 60% versus surgery alone.
Angus Liuu Oct 18, 2025 10:30am
Libtayo bottle and box

FDA approves Regeneron's Libtayo for adjuvant use in CSCC

Oct 9, 2025 11:00am
Merck groundbreaking

Merck grows again in Va. with $3B small-molecule drug plant

Oct 20, 2025 9:00am
Britain Big Ben United Kingdom London

Big Pharma's 'Brexit' draws call for anticompetition probe

Oct 3, 2025 11:30am
Winrevair

Merck releases results from successful trial of Winrevair

Sep 30, 2025 8:00am
David Ricks Eli Lilly CEO

England is not attractive place for investment, Lilly CEO says

Sep 24, 2025 10:52am